Haley Wilson

The master of scRNA-seq in brain tumors, @MarioSuva, always pushing the boundaries of dataset size and information per sample. In his keynote, corrects the record for the field that there are not cell state shifts toward MES at GBM recurrence. Actually no consistent changes - our therapies are not dramatically changing the malignant cell states or TIME states (the treatments also don't work). Data from >120 patients samples from around the world with matched primary and recurrent pairs #SNO2025

Proteintech Microscopy Competition is back for 2025! Submit your most striking immunofluorescence microscopy images by October 5th for a chance to win some awesome prizes! ptglab.com/news/microscop…

I’m thrilled to share that I have started a new role as a part-time Brand Ambassador with Proteintech Group! Proteintech is a global leader in biotechnology and I’m excited to represent a company truly created with scientists in mind!

In today's Cell, we propose a “developmental constraint” model whereby cancer cell state plasticity is restricted by the organism’s developmental map to access progenitor-like states and differentiated-like states of adjacent lineages.🧵⬇️ sciencedirect.com/science/articl… @AyushiPatel3994

CODA day! The CODA team at @JohnsHopkins maps pancreatic precursor lesions in 3D and at single-cell level. First 3D spatial genomic maps of large tissue samples. A human pancreas contains a staggering ~1000 lesions, some showing multifocality. Here: nature.com/articles/s4158…

Exciting news 🎉 We are thrilled to announce that the Sidney Kimmel Cancer Center has achieved "Comprehensive Cancer Center" designation, the highest recognition awarded by @theNCI! jeffersonhealth.org/about-us/news/…

Bacterial signals can be detected in brain metastasis tissue and might be associated with delayed progression, says our Dr. Golnaz Morad of results presented at #AACR24 (Abstract 1283). Learn more here: bit.ly/4cLlF8z @GolnazMorad @JenWargoMD #BrainTumor #EndCancer

Great job by @lariaccarvalho detailing responses to RMC7977 in NRAS mutant melanoma. @MoffittNews #AACR24

Proud to share my student's recent @NatureComms paper!: Androgen drives melanoma invasiveness by inducing tumorigenic fucosylation. @Qianliu070's study helps explain why melanomas are more aggressive w/ poorer outcomes in men. go.nature.com/49fJzqT @CancerBiol_PhD @MoffittNews

Today we honor the melanoma community this #WorldCancerDay, a day that raises awareness around cancer prevention, detection & treatment. We encourage you to learn more about the MRF as we strive to eradicate melanoma through research, education & advocacy- buff.ly/3SbpB8v

Very excited to share new work from the lab dissecting mechanisms of liver-metastatic organotropism in melanoma and other cancers. Huge congrats to fearless post-doc @meri_rogava (on the job market!) who led this multi-year study! Below a brief summary... nature.com/articles/s4301…

So lucky to have best friends in life and lab! Celebrating passing my comprehensive exam and becoming a PhD candidate🥲🎉 @CaseyStefanski @SigneCaksa

Had an amazing time last week presenting my poster at @SocietyMelanoma! Thanks @AndrewEAplin for encouraging every opportunity to present my work and network with incredible scientists.

Amazing time with the lab and the melanoma research community at this year’s SMR @SocietyMelanoma. So grateful to be a part of this field and have such incredible people as colleagues! Had so much fun at the gala and @AndrewEAplin got us all out on the dance floor! #SMR23

From yesterday evening’s @SocietyMelanoma Awards Ceremony. Dr. Eva Hernando-Monge of @nyugrossman receiving the Estela Medrano Memorial Award in recognition of her outstanding contributions to #melanoma #research. Congrats! #SMR23

Very touching words from @ProfRScolyerMIA at the Awards Ceremony at #SMR23 upon receiving the Lifetime Achievement Award. So well deserved. Standing ovation for Dr Scolyer #endcancer

Dr. Susan Swetter of @StanfordMed presenting on Increasing DEI in #melanoma #research: from bench to beside to community at #SMR23

Signe ⁦@ResearchAtJeff⁩ speaking on TGM2 and drug tolerant persisters in melanoma #SMR2023. Great talk.

2021 Medical Student Award recipient Signe Caksa (Mentor: @AndrewEAplin) from @JeffersonUniv presented her work on a protein whose expression is increased in melanoma and may impact immunotherapy response. #SMR2023 @societymelanoma

Excited to share our latest preprint! In thie work we showed that acral melanomas, a melanoma subtypes occurring on the skin of palms, soles & nailbeds, evolve very differently from melanomas arising from sun-exposed skin (or cutaneous melanomas).biorxiv.org/content/10.110…